New insights on CRISPR/Cas9-based therapy for breast Cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Text and Data Mining valid from 2021-04-29
Version of Record valid from 2021-04-29
13 January 2021
12 April 2021
29 April 2021
All authors confirm their participation and approve the submission.
The authors declare no conflict of interests.